for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Hims & Hers Health Inc

HIMS.N

Latest Trade

8.24USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

6.71

 - 

25.32

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
8.24
Open
--
Volume
--
3M AVG Volume
53.35
Today's High
--
Today's Low
--
52 Week High
25.32
52 Week Low
6.71
Shares Out (MIL)
203.23
Market Cap (MIL)
1,609.50
Forward P/E
-22.48
Dividend (Yield %)
--

Next Event

Hims & Hers Health Inc Annual Shareholders Meeting

Latest Developments

More

Hims & Hers Health Inc Reports Partnership With REVOLVE

Spencer Lee to Step Down as Hims & Hers Health CFO

Hims & Hers Health Posts Q2 Loss Per Share Of $0.05

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Hims & Hers Health Inc

Hims & Hers Health, Inc., formerly Oaktree Acquisition Corp., is a telehealth platform that connects consumers to licensed healthcare professionals. The Company has designed and build a cloud-based technology, through which it offers a range of health and wellness products and services. Its platform helps customers to access medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more. The Company has partnered with dermatology experts to offer access to formulated topical creams for customers experiencing acne and signs of premature aging, such as wrinkles. It offers telehealth solutions with combined access to a distributed provider network, digital prescriptions, cloud pharmacy, and consumer engagement strategies, all delivered through mobile and Web interfaces. The Company's Products include shampoo, conditioner, biotin gummies, anti-aging cream, vitamin c serum, acne cream and moisturizer.

Industry

Biotechnology & Drugs

Contact Info

2269 Chestnut St, #523

SAN FRANCISCO, CA

94123

United States

+1.415.8510195

http://www.forhims.com/

Key Stats

2.25 mean rating - 4 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2020

0.1K

2021(E)

0.3K
EPS (USD)

2020

-0.230

2021(E)

-0.368
Price To Earnings (TTM)
--
Price To Sales (TTM)
14.24
Price To Book (MRQ)
5.45
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-24.69
Return on Equity (TTM)
-23.42

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up